AstraZeneca, JOHNSON & JOHNSON RESUME COVID VACCINE TRIALS IN U.S.

Highlights

• AstraZeneca said the Food and Drug Administration (FDA) today authorized the restart in the U.S., following the resumption of trials in other countries in recent weeks

• The drugmaker further said that the FDA reviewed all safety data from trials globally and concluded it was safe to resume the trial

• Soon after AstraZeneca, Johnson & Johnson said it was preparing to resume recruit....